ArticleBreast cancer research and treatment2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer.
Sophia Zelizer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it